Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Determining which travel rewards credit card is best can enhance your travel experiences. Explore your options for the best fit.
23,300 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
PepsiCo stock faces a potential move toward $180 as analysts cite World Cup-driven demand, cost cuts, and internation...
As markets swing in June 2026, retirees with over million are shifting from pure cash to a five-year ladder that blen...
A dramatic reconfiguration of the Dow Jones Industrial Average will take effect on June 29. Verizon Sunt exits and Al...
Chainlink announces a landmark cross-border banking pact linking European and Korean lenders to test instant FX settl...
Bitcoin price crashes below the key $60,000 level as MicroStrategy shares slide, signaling renewed pressure across di...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Glenn Kelman has joined Greylock Partners as an executive in residence, months after stepping down from Redfin and fo...
A major insider purchase by BORR's Executive Director has investors buzzing. This article breaks down what the move c...
The Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...
Investors weighing JEPQ for monthly income face a trade-off between steady payouts and long-term growth. A 20-year lo...
A two-day pension fund rebalance could move about $30 billion of U.S. stocks, posing near-term volatility but often a...